Ophthalmic Brachytherapy

In many centres, brachytherapy is the first choice of treatment for uveal melanomas. This modality is also useful for some retinoblastomas and conjunctival melanomas. With this form of radiotherapy, a radioactive plaque containing ruthenium-106 or iodine-125 is sutured to the wall of the eye, adjacent to the tumor, and left in place for several days until the required dose of radiation has been delivered.



For more information, please also see our Brochure Ophthalmic Brachytherapy (EN).

Eckert & Ziegler BEBIG offers a series of reliable products for temporary brachytherapy of eye cancers. The company is the only global provider of Ru-106 (Ruthenium-106) Eye Applicators used to treat ocular melanoma and retinoblastoma. The  product portfolio  also includes  the  COMS Eye  Applicators used  together with the IsoSeed® I-125.

For more information, please also see our Brochure Ophthalmic Brachytherapy (EN).